Literature DB >> 12911681

The impact of therapeutic doses of paracetamol on serum total antioxidant capacity.

S L Nuttall1, J N Khan, G H Thorpe, N Langford, M J Kendall.   

Abstract

INTRODUCTION: A link between regular paracetamol intake and asthma in adults has recently been postulated. Detoxification of paracetamol may deplete stores of glutathione, which is one of the major antioxidants present in the lung. A reduced source of glutathione in the lung may lead to increased oxidative damage to the epithelium and hence increased frequency and severity of asthma attacks in susceptible individuals.
AIM OF STUDY: This study aimed to determine whether regular intake of maximum therapeutic doses of paracetamol reduced serum antioxidant capacity in healthy volunteers.
METHODS: Fifteen young healthy volunteers (nine men, six women, mean age 21.3 years, range 19-32) took maximum therapeutic doses of paracetamol (1 g four times a day) for 14 days. On days 0 and 14 blood samples were taken at baseline and hourly for a period of 4 h following ingestion of 1 g paracetamol. Single venous blood samples were collected 1 h after ingestion of 1 g paracetamol on days 4, 7 and 10. Blood samples were analysed for serum paracetamol concentration and total antioxidant capacity.
RESULTS: Mean total antioxidant capacity was significantly reduced over the 3-h post-dosing on both days 0 and 14 (P < 0.01). The results from days 4, 7 and 10 showed a trend towards reduced antioxidant activity over time. On day 14 values were consistently lower compared with the corresponding times on day 0 (P < 0.01 at 0, 1, 3 and 4 h, P < 0.05 at 2 h).
CONCLUSIONS: Chronic ingestion of maximum therapeutic doses of paracetamol depletes serum antioxidant capacity in healthy volunteers in as few as 14 days, possibly by a reduction in glutathione. This may have implications for analgesic use in asthmatic individuals. Further studies are now required to assess the impact of paracetamol on antioxidant defences in the lung.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12911681     DOI: 10.1046/j.1365-2710.2003.00493.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  27 in total

1.  Differential effects of acetaminophen on enzymatic and non-enzymatic antioxidant factors and plasma total antioxidant capacity in developing and adult rats.

Authors:  Abolfazl Dadkhah; Faezeh Fatemi; Somaieh Kazemnejad; Yusef Rasmi; Javad Ashrafi-Helan; Abdolamir Allameh
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

2.  Acetaminophen and asthma.

Authors:  Akashdeep Singh
Journal:  CMAJ       Date:  2009-10-27       Impact factor: 8.262

3.  Use of Negative Control Exposure Analysis to Evaluate Confounding: An Example of Acetaminophen Exposure and Attention-Deficit/Hyperactivity Disorder in Nurses' Health Study II.

Authors:  Zeyan Liew; Marianthi-Anna Kioumourtzoglou; Andrea L Roberts; Éilis J O'Reilly; Alberto Ascherio; Marc G Weisskopf
Journal:  Am J Epidemiol       Date:  2019-04-01       Impact factor: 4.897

4.  Neurodevelopmental problems at 18 months among children exposed to paracetamol in utero: a propensity score matched cohort study.

Authors:  Richelle Vlenterie; Mollie E Wood; Ragnhild Eek Brandlistuen; Nel Roeleveld; Marleen Mhj van Gelder; Hedvig Nordeng
Journal:  Int J Epidemiol       Date:  2016-12-01       Impact factor: 7.196

5.  Effect of prenatal exposure to fine particulate matter and intake of Paracetamol (Acetaminophen) in pregnancy on eczema occurrence in early childhood.

Authors:  Wieslaw Jedrychowski; John D Spengler; Umberto Maugeri; Rachel L Miller; Dorota Budzyn-Mrozek; Matt Perzanowski; Elzbieta Flak; Elzbieta Mroz; Renata Majewska; Irena Kaim; Frederica Perera
Journal:  Sci Total Environ       Date:  2011-10-01       Impact factor: 7.963

6.  Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children.

Authors:  Joanne E Sordillo; Christina V Scirica; Sheryl L Rifas-Shiman; Matthew W Gillman; Supinda Bunyavanich; Carlos A Camargo; Scott T Weiss; Diane R Gold; Augusto A Litonjua
Journal:  J Allergy Clin Immunol       Date:  2014-10-28       Impact factor: 10.793

7.  Have the efforts to prevent aspirin-related Reye's syndrome fuelled an increase in asthma?

Authors:  C C Johnson; D R Ownby
Journal:  Clin Exp Allergy       Date:  2011-03       Impact factor: 5.018

Review 8.  The association between acetaminophen and asthma: is there anything to learn from the upper airways?

Authors:  Haejin Kim; Christine C Johnson
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-02

9.  Prenatal exposure to acetaminophen and respiratory symptoms in the first year of life.

Authors:  Victoria Persky; Julie Piorkowski; Eva Hernandez; Noel Chavez; Cynthia Wagner-Cassanova; Carmen Vergara; Darlene Pelzel; Rachel Enriquez; Silvia Gutierrez; Adela Busso
Journal:  Ann Allergy Asthma Immunol       Date:  2008-09       Impact factor: 6.347

Review 10.  Acetaminophen use: a risk for asthma?

Authors:  Henning Allmers; Christoph Skudlik; Swen Malte John
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.